Vcanbio Cell & Gene Engineering Corp Ltd

Zhongyuan Union Cell & Gene Engineering released its 2026 interim report. Total operating revenue was 659 million yuan, a decrease of 56.9978 million yuan from the same period last year, down 7.96 percent year on year. Net profit attributable to the parent company was 61.0484 million yuan. Net cash inflow from operating activities was 133 million yuan. The asset-liability ratio was 28.45 percent, gross margin was 70.95 percent, return on equity was 1.63 percent, and diluted earnings per share was 0.13 yuan. Total asset turnover was 0.12 times, down 8.58 percent year on year. Inventory turnover was 0.82 times, down 14.07 percent year on year. The company had 36,700 shareholders, and the top ten shareholders held 36.16 percent of total share capital.